WEBSITE BSE:534733 NSE: AERPACE Inc. Year: 2011 Industry: Trading My Bucket: Add Stock
Last updated: 11:17
No Notes Added Yet
Aerpace Industries Limited is an Indian multinational company specializing in the design, manufacturing, and supply of advanced aerospace and defense systems. Established in 1982 and headquartered in Bengaluru, the company has emerged as a leading player in the aeronautics industry, serving both domestic and international markets. The company's origins can be traced back to a group of visionary engineers and aviation enthusiasts who recognized the potential for indigenous aerospace manufacturing in India. One of Aerpace's flagship products is t...Read More
Aerpace Industries Limited is an Indian multinational company specializing in the design, manufacturing, and supply of advanced aerospace and defense systems. Established in 1982 and headquartered in Bengaluru, the company has emerged as a leading player in the aeronautics industry, serving both domestic and international markets. The company's origins can be traced back to a group of visionary engineers and aviation enthusiasts who recognized the potential for indigenous aerospace manufacturing in India. One of Aerpace's flagship products is the 'Garuda' series of UAVs, which have been widely adopted by the Indian Armed Forces and various international defense agencies for surveillance, reconnaissance, and combat operations. The company has also contributed significantly to the development of India's space program, manufacturing critical components for satellite launch vehicles and spacecraft. ...Read Less
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Market Cap ₹394 Cr.
Stock P/E -53.3
P/B 9.4
Current Price ₹25.6
Book Value ₹ 2.7
Face Value 1
52W High ₹32.5
Dividend Yield 0%
52W Low ₹ 16.7
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
| #(Fig in Cr.) | Sep 2023 | Dec 2023 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Expenditure | 0 | 1 | 1 | 1 | 1 | 3 | 1 | 3 | 2 |
| Operating Profit | -0 | -0 | -1 | -1 | -1 | -3 | -1 | -3 | -2 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 1 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | -0 | -0 | -1 | -1 | -3 | -3 | -2 | -4 | -2 |
| Provision for Tax | 0 | -0 | 0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Profit After Tax | -0 | -0 | -1 | -1 | -2 | -3 | -2 | -3 | -2 |
| Adjustments | 0 | 0 | 0 | -0 | 0 | 1 | 0 | 1 | -0 |
| Profit After Adjustments | -0 | -0 | -1 | -1 | -2 | -3 | -2 | -3 | -2 |
| Adjusted Earnings Per Share | -0 | -0 | -0.1 | -0 | -0.2 | -0.2 | -0.1 | -0.2 | -0.2 |
| #(Fig in Cr.) | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|
| Net Sales | 0 | 0 | 0 | 0 |
| Other Income | 2 | 0 | 1 | 0 |
| Total Income | 2 | 0 | 1 | 0 |
| Total Expenditure | 2 | 2 | 6 | 9 |
| Operating Profit | 1 | -1 | -6 | -9 |
| Interest | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 1 | 3 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | -2 | -8 | -11 |
| Provision for Tax | 0 | 0 | -0 | 0 |
| Profit After Tax | 0 | -2 | -7 | -10 |
| Adjustments | 0 | 0 | 1 | 2 |
| Profit After Adjustments | 0 | -1 | -7 | -10 |
| Adjusted Earnings Per Share | 0 | -0.1 | -0.4 | -0.7 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 0% | 0% | 0% | 0% |
| Operating Profit CAGR | 0% | 0% | 0% | 0% |
| PAT CAGR | 0% | 0% | 0% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | 9% | 121% | 51% | 25% |
| ROE Average | -24% | -14% | -14% | -14% |
| ROCE Average | -23% | -12% | -12% | -12% |
| #(Fig in Cr.) | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|
| Shareholder's Funds | 4 | 13 | 49 |
| Minority's Interest | 0 | 4 | 3 |
| Borrowings | 0 | 0 | 0 |
| Other Non-Current Liabilities | 1 | 1 | 12 |
| Total Current Liabilities | 1 | 2 | 5 |
| Total Liabilities | 5 | 19 | 69 |
| Fixed Assets | 1 | 5 | 19 |
| Other Non-Current Assets | 0 | 7 | 47 |
| Total Current Assets | 4 | 6 | 3 |
| Total Assets | 5 | 19 | 69 |
| #(Fig in Cr.) | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|
| Opening Cash & Cash Equivalents | 0 | 0 | 1 |
| Cash Flow from Operating Activities | -0 | -3 | -5 |
| Cash Flow from Investing Activities | 0 | -3 | -37 |
| Cash Flow from Financing Activities | -0 | 8 | 41 |
| Net Cash Inflow / Outflow | -0 | 1 | -1 |
| Closing Cash & Cash Equivalent | 0 | 1 | 0 |
| # | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|
| Earnings Per Share (Rs) | 0.01 | -0.1 | -0.43 |
| CEPS(Rs) | 0.04 | -0.1 | -0.4 |
| DPS(Rs) | 0 | 0 | 0 |
| Book NAV/Share(Rs) | 0.34 | 0.93 | 3.16 |
| Core EBITDA Margin(%) | 0 | 0 | 0 |
| EBIT Margin(%) | 0 | 0 | 0 |
| Pre Tax Margin(%) | 0 | 0 | 0 |
| PAT Margin (%) | 0 | 0 | 0 |
| Cash Profit Margin (%) | 0 | 0 | 0 |
| ROA(%) | 2.43 | -15.24 | -16.81 |
| ROE(%) | 3.61 | -22.61 | -24.09 |
| ROCE(%) | 6.62 | -19.91 | -23.14 |
| Receivable days | 0 | 0 | 0 |
| Inventory Days | 0 | 0 | 0 |
| Payable days | 0 | 0 | 0 |
| PER(x) | 132.09 | 0 | 0 |
| Price/Book(x) | 4.78 | 13.62 | 7.61 |
| Dividend Yield(%) | 0 | 0 | 0 |
| EV/Net Sales(x) | 0 | 0 | 0 |
| EV/Core EBITDA(x) | 33.82 | -143.71 | -63.2 |
| Net Sales Growth(%) | 0 | 0 | 0 |
| EBIT Growth(%) | 0 | -753.25 | -331.65 |
| PAT Growth(%) | 0 | -1525.1 | -301.91 |
| EPS Growth(%) | 0 | -924.39 | -321.4 |
| Debt/Equity(x) | 0.07 | 0 | 0 |
| Current Ratio(x) | 5.44 | 3.49 | 0.57 |
| Quick Ratio(x) | 5.44 | 3.49 | 0.57 |
| Interest Cover(x) | 2.35 | -12.68 | -17.31 |
| Total Debt/Mcap(x) | 0.01 | 0 | 0 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 50.72 | 50.72 | 50.72 | 46.53 | 46.6 | 45.35 | 45.35 | 44.93 | 44.74 | 45.24 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 49.28 | 49.28 | 49.28 | 53.47 | 53.4 | 54.65 | 54.65 | 55.07 | 55.26 | 54.76 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 6.93 | 6.93 | 6.93 | 6.96 | 6.97 | 6.98 | 6.98 | 6.91 | 6.88 | 6.96 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 6.74 | 6.74 | 6.74 | 7.99 | 7.98 | 8.41 | 8.41 | 8.47 | 8.5 | 8.43 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13.67 | 13.67 | 13.67 | 14.95 | 14.95 | 15.39 | 15.39 | 15.39 | 15.39 | 15.39 |
* The pros and cons are machine generated.
You May Also Know About
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
ChatGPT
Claude
Perplexity
